Trial Profile

Clinical study of landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 12 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Landiolol (Primary) ; Diltiazem
Indications Atrial fibrillation; Atrial flutter
Focus Therapeutic Use
Acronyms JL-KNIGHT

Most Recent Events

23 Feb 2012 Results published in Circulation Journal.
16 Oct 2010 Results presented at the 2010 Annual Meeting of the American Society of Anesthesiologists
14 Jan 2010 Planned end date (1 Feb 2010) added University Hospital Medical Information Network - Japan record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com